We used the in vitro genetics approach to investigate the relationship between the mechanisms of peptidyl complexed with a transition state analog, these are the only nucleotides whose reactive groups are positioned transfer and peptide release and to gain insights into the possible function role of C2063, A2451, U2585, and within 5 Å of the putative tetrahedral carbon center (Figure 1B, green sphere) at which the reaction of peptide A2602 in these reactions. We found that while peptidyl transfer tolerates base changes at any of the studied bond formation takes place . All four nucleotides are universally conserved. A plethora nucleotides, some mutations at A2602 specifically eliminated the peptide release activity. This suggests a critiof biochemical and structural data implicate at least three of these nucleotides as functionally important for cal role of A2602 in the hydrolysis of peptidyl-tRNA and hints at a distinct mechanism for the peptide release the activity of the peptidyl transferase center. K.R. Lieberman and A.E. Dahlberg, personal communiplexes, the N3 of A2451 is located within 4 Å from the tetrahedral center of the transition state analog and was cation). Therefore, in order to study the effects of the mutations, we used an in vitro reconstitution system. proposed to directly participate in the chemical catalysis of the peptidyl transfer, acting as a general base-acid Functionally active T. aquaticus large ribosomal subunits were assembled from in vitro transcribed 23S rRNA to promote the formation and subsequent resolution of (wild-type or mutant), 5S rRNA, and 50S subunit proteins 2000) , and the release of 1999). These results suggest that neither U2585 nor formyl-methionine was quantified by scintillation count-C2063 are vitally critical for any of the two reactions ing or by paper electrophoresis. Similar to their activity catalyzed by the peptidyl transferase center. in the peptidyl transferase reaction, ribosomes with any A different picture emerged with ribosomes conbase substitution at A2451 were readily able to hytaining mutations at position A2602. The 2602C mutation drolyze peptidyl-tRNA (Figures 2A and 2B) . Though the as well as the deletion of A2602 (A2602⌬) completely activity of the mutant ribosomes was somewhat deeliminated RF1-dependent peptidyl-tRNA hydrolysis creased compared to the wild-type, the initial rate of ( Figure 2C ). Even with prolonged incubation, we were peptidyl-tRNA hydrolysis differed no more than 6-fold at unable to detect any ribosome-catalyzed release of for-25ЊC. The 2451U mutation is known to render ribosomes myl-methionine from formyl-Met-tRNA. The other two resistant to chloramphenicol (Kearsey and Craig, 1981;  mutants (2602U and 2602G) also showed diminished Thompson et al., 2001 ). Indeed, while 250 M chlorampeptide release activities, with the initial rates of the phenicol inhibited the peptide release activity of reconreaction reduced by a factor of 25 and 250, respectively stituted wild-type ribosomes by ‫,%05ف‬ the ability of the ( Figure 2C ). 2451U, 2451C and 2451G mutants to hydrolyze peptidylThe severe effect of some of the 2602 mutations on tRNA remained unaffected (data not shown). This conthe peptide release drastically contrasted the virtual lack firms that the peptide release was indeed the function of an effect of any of the 2602 mutations on the peptidyl of the mutant ribosomes rather than a result of contamination with wild-type ribosomes.
transferase activity of ribosomes coming from the same fold the concentration required to saturate the reaction catalyzed by the native T. aquaticus ribosomes. Further tions were resistant to the drug in the SPARK-Pmn reaction (data not shown). Therefore, we are confident that (up to additional 10-fold) increase of the RF concentration did not compensate for the decreased peptide rethe high levels of the peptidyl transferase activity in our experiments were indeed attributable to the 2602 mutant lease activity of the mutant ribosomes carrying the A2602 mutations ( Figure 2D ). Thus, the compromised ribosomes rather than wild-type contamination. activity of the 2602 mutants does not appear to be due to diminished RF binding.
A2602 Mutations Do Not Significantly Perturb Ligand Binding
To further verify whether the A2602 mutations directly affect the ability of the ribosome to hydrolyze peptidylThe dramatically different effect of base changes at A2602 on peptide bond formation and peptide release tRNA as opposed to ligand binding, the activity of the (Table 2 ). In addition, the 2602G mutant, or noncognate tRNA were used to stimulate formyl-MettRNA hydrolysis (Figure 3) . The results clearly demonwhich in the RF1-mediated assay showed some activity, was inactive in the RF-independent reaction. Only the strated that the presence of tRNA in the A site is required to stimulate the peptide release-only deacylated tRNA 2602U mutant exhibited low residual activity (4%). This observation agreed well with the previous conclusion cognate to the A site codon was able to stimulate the reaction rate. Thus, the ligands of the RF-independent that the inability of the 2602 mutants to hydrolyze peptidyl-tRNA was not due to reduced affinity of the RF to peptide release assay are similar to those of the twotRNA SPARK transpeptidation reaction, with the only the mutant ribosome in the standard assay. In contrast to the 2602 mutants, ribosomes with mutations at A2451, difference that aminoacyl-tRNA is required for transpeptidation, while deacylated tRNA is needed for the U2585, or C2063 were active in the RF-independent assay; the relative activities were generally comparable peptide release. Since the 2602 mutant ribosomes from the same reconstitution pool showed high activities in to those measured in the RF-mediated peptide release (data not shown).
the peptidyl transferase assays (in the absence or in the presence of acetone; Tables 1 and 2 ), but were inactive Still, the possibility remained that base alterations at A2602 interfered with binding of the reaction substrate, in RF-independent peptide release, the effect of the mutations on the peptidyl-tRNA hydrolysis could hardly peptidyl-tRNA, and/or binding of deacylated tRNA in the factor-independent hydrolysis reaction. To address this be explained by altered tRNA binding to either the P or the A site. question, it was useful to compare the substrates of the RF-independent peptide release, where several of Thus, the complete loss (with 2602C or 2602⌬ mutants) or the dramatic reduction (with 2602G and 2602U A2602 mutants were completely inactive, with the twotRNA SPARK transpeptidation reaction, where the same mutants) of the peptide release activity observed in both the RF-mediated and the RF-independent assays does mutants showed high activities (Tables 1 and 2 ). In the two-tRNA SPARK, N-protected aminoacyl-tRNA binds not appear to be related to the reduced ligand binding and is more consistent with the direct involvement of to the ribosomal P site and acceptor aminoacyl-tRNA binds in the A site. Under the conditions of the RF-A2602 in peptide release. Furthermore, the divergent effects of A2602 mutations on peptidyl transfer and pepindependent peptide release assay, peptidyl-tRNA is bound to the P site while deacylated tRNA can potentide release indicate that these two reactions are pro- moted by distinct elements of the ribosomal peptidyl streptogramin B-type drugs (pristinamycin I and quinupristin) that stimulated transpeptidation had no effect transferase center.
on the peptidyl-tRNA hydrolysis. Though the disparity in action of some antibiotics could be potentially due
Differential Effects of Antibiotics on Peptide Bond Formation and Peptide Release
to the different nature of the A site substrates in the peptidyl transfer and peptide release assays, the results The latter conclusion was corroborated by idiosyncratic inhibition pattern of these two reactions by some antibiwere generally consistent with the idea that distinctive features of the peptidyl transferase center may be reotics. Following early experiments with E. coli ribosomes (Vogel et al., 1969) , we examined the sensitivity of pepsponsible for these two activities. tide bond formation and nascent peptide release catalyzed by native T. aquaticus ribosomes toward an exDiscussion tended collection of 50S subunit-targeted antibiotics. In order to facilitate comparison with the previous data, a
We studied the functional effects of mutations at four universally conserved nucleotides located in close proxpuromycin-based SPARK-Pmn assay was used to monitor peptide bond formation (Polacek et al., 2002) while imity to the peptidyl transferase active site and found that only mutations at A2602 of 23S rRNA abolish the a standard formyl-Met release assay was used to monitor the peptide release activity (see above). Finally, in hydrolysis of peptidyl-tRNA. Neither of the studied mutations abolish peptide bond formation. These results order to eliminate possible effects of the drugs on RF binding, we tested the antibiotic effects in the RF-indesuggest a critical and distinct role for A2602 in peptide release during termination of protein synthesis. pendent peptide release assay (Caskey et al., 1971) . In all three assays the P site was occupied by formyl-MetThe in vitro reconstitution system used in this study provides a valuable advantage of obtaining ribosomes tRNA; the reactions were performed in the presence of excess amounts (100 M) of antibiotics (250 M for carrying mutations at functionally important rRNA positions that are known to be lethal in vivo. It is important chloramphenicol) and stopped at a time point corresponding to the slope on the time curve of the correto point out, however, the intrinsic limitations of this system. Only small quantities of mutant 23S rRNA can sponding reactions.
In a general agreement with the data obtained prebe prepared by in vitro transcription, which puts limits on the amount of assembled ribosomes available for viously with E. coli ribosomes (Caskey et al., 1971 ), some antibiotics, in particular hygromycin A and sparsomycin, biochemical and kinetic studies. Additionally, due to relatively inefficient in vitro assembly, the activities of strongly inhibited the activity of T. aquaticus ribosomes in all three assays (Ͻ3% of the control) at the tested in vitro reconstituted ribosomal subunits never reach those of native ribosomes (Ͻ20% and ‫%05ف‬ for peptide concentrations (Figure 4, group I) . Several other drugs (group III), including macrolides (erythromycin, telithrobond formation and peptide release, respectively). Furthermore, the rates of the reactions catalyzed by in vitro mycin, RU 69874), evernimicin, and linezolid, did not inhibit any of the studied reactions. Notably, however, assembled ribosomes varied sometimes between different reconstituted pools (up to 5-fold). Therefore, a spea number of antibiotics (group II) strongly interfered with the peptidyl transfer (less then 4% of the remaining cial effort was made to minimize the effects of such variations. All mutant 23S rRNAs used in any experimenactivity) but were notably less active in inhibiting peptide release, especially in the RF-independent assay (more tal series were always transcribed in parallel reactions, and wild-type and mutant ribosomes were assembled than 50% of the remaining activity). The difference was especially dramatic with lincomycin and its derivative simultaneously. Most importantly, in every experiment, ribosomes from the same assembly pool were always clindamycin, which completely failed to inhibit the factor-independent peptidyl-tRNA hydrolysis. In addition, tested in parallel in peptidyl transferase and peptide release assays, so that the lack of activity in only one with ligand binding, it seems reasonable to conclude that these mutations directly affect the ability of the of the two assays could not be attributed to assembly failures.
ribosome to catalyze the peptide release reaction. The remarkable difference in the effects of A2602 muThe peptidyl transferase assay showed that in spite of the central position of the residues C2063, A2451, tations on peptidyl transfer and peptide release may reflect the idiosyncratic nature of the chemical transfor-U2585, and A2602 in the peptidyl transferase active site ( Figure 1B) , mutations at these residues did not dramatimation that takes place during these two reactions. The attack of the aminoacyl-tRNA ␣-aminogroup, a strong cally affect the overall in vitro rates of peptide bond formation (Table 1) . Although the assays used in this nucleophile, on the ester bond during peptide bond formation can occur with reasonably high rates upon work do not directly allow addressing the catalytic rate of peptidyl transfer, the mere fact that the mutant riboproper substrate orientation (Nierhaus et al., 1980) . Hence, the entropic factor-correct positioning of the somes are readily able to catalyze transpeptidation shows that the nucleotide alterations do not impede the peptidyl-and aminoacyl-tRNA substrates-may be the main acceleration factor of peptide bond formation. main acceleration factor provided by the ribosome for this reaction. Similarly, mutations at C2063, A2451, and Since substrate binding requires multiple interactions between the ribosome and tRNAs (Yusupov et al., 2001), U2585 did not dramatically affect the overall in vitro rates of peptidyl-tRNA hydrolysis. In striking contrast, alteration of single nucleotides in the peptidyl transferase active site may not produce a dramatic effect on some base changes at A2602 had a profound negative effect on the peptide release: the 2602C mutation and the overall rate of the reaction. In contrast, hydrolysis of the ester bond during peptide release, driven by a the deletion of A2602 abolished the ribosome-mediated peptidyl-tRNA hydrolysis in an RF-dependent or RFless nucleophilic water oxygen, should depend more strongly on chemical (possibly, general base) catalysis independent reactions while ribosomes harboring the 2602G mutation exhibited notably reduced activities involving activation of the water molecule (Jencks, 1969). In the latter case, alteration of a catalytic nucleo- (Tables 1 and 2 ).
It seems unlikely that mutations at 2602 interfere with tide will affect the reaction rate much more severely, resulting in a dramatic drop in product formationbinding of the reaction substrates to the ribosome. Increasing the RF concentration could not rescue the acsimilar to what we have observed in our experiments with 2602 mutant ribosomes. Thus, it is possible that tivity of A2602 mutants (Figure 2D) , indicating that at least with the mutants whose residual activity could the two critical reactions mediated by the peptidyl transferase center during protein synthesis, transpeptidation be measured (2602U and 2602G), RF binding was not limiting. Additionally, the 2602G, 2602C, and the 2602 and peptide release, may be promoted through different catalytic mechanisms potentially involving distinct eledeletion mutants were inactive in an RF-independent peptide release assay where hydrolysis of peptidylments of the peptidyl transferase center. In line with this interpretation are the differential effects of antibiotics tRNA in the P site is stimulated by the binding of deacylated-tRNA in the A site (Table 2 and 
